A new kind of medical eye drops have been submitted for approval to the American FDA which have the potential to help users read without glasses.

The drug, a pilocarpine solution, works by treating the symptoms of presbyopia, also known as near-sightedness, a condition that becomes worse as people age. Presbyopia is caused by hardening of the lens, which loses the elasticity it needs to focus from far-off objects to closer ones.
Two randomized trials of 750 patients has found the drug to be safe and effective, in general increasing the ability of the people to read by up to three lines in low light. The drops begin working 15 minutes after they are used but reach peak performance after an hour.
If approved, the drops will become the first treatment for presbyopia.
Judiciary is facing challenges in journey to deliver justice: CJP Afridi
- 13 hours ago
Arab, Muslim leaders to meet in Qatar to denounce Israeli attack
- 9 hours ago
Blasphemy case: Engr Muhammad Ali Mirza remanded in NCCIA custody for seven days
- 14 hours ago

U.S. loss to South Korea another misstep with World Cup prep time running out
- 12 hours ago
PM suspends collection of power bills from consumers in flood-affected areas
- 8 hours ago

World Athletics Championships begin in Tokyo
- 14 hours ago
Wasim Akram tells Pakistan, India to forget noise and ‘enjoy’ Asia Cup clash
- 13 hours ago

Apple is giving iPhone 14 and 15 users another free year of satellite features
- 21 minutes ago

Another person dies of Naegleria in Karachi
- 8 hours ago
Nepal returns to calm as first woman PM takes charge, visits wounded
- 8 hours ago
President expresses Pakistan’s full support for China’s vision of civilisation exchange, mutual learning
- 12 hours ago

Gold prices decline in Pakistan today
- 14 hours ago